Autoimmune Diseases and HIV


Autoimmune diseases arise when inherited autoimmunity progress to pathogenic autoimmunity. Genetic factors as well as environmental causes dictate this development. The global market size of Autoimmune Disease Therapeutics was $109,833 million in 2017 and is expected to reach $153,320 million by the end of 2025, with a CAGR of 4.2% 2018-2025.



HIV is a category of diseases caused by human immunodeficiency virus infection. HIV weakens the immune system and impedes the ability of the body to combat disease as they destroy T cells, macrophages and dendritic cells. There is no treatment for HIV at the moment, but there are many clinical studies devoted to a cure. Developing an HIV vaccine would save millions of lives. Share your research findings on Autoimmunity and HIV to the world; this can be possible by our Immunology Congress.



 


    Related Conference of Autoimmune Diseases and HIV

    November 08-09, 2021

    International Conference on Immunology Research

    Las Vegas, USA
    December 17-18, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    December 20-21, 2021

    9th World Summit on Immunology & Immunotherapy

    Prague, Czech Republic
    December 23-23, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    December 23-23, 2021

    3rd International Conference on Viral Infection and Immune Response

    Amsterdam, Netherlands
    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    37th International Conference on Immunology

    Brussels, Aland Islands
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan
    May 02-03, 2022

    16th International Conference on European Immunology

    Zurich, Switzerland

    Autoimmune Diseases and HIV Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in